Talk:Siew C. Ng

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard. If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Articles for creation This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information. This article was accepted from this draft on 26 June 2025 by reviewer Timtrent (talk · contribs). Biography: Science and Academia Biography portal This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation. This article is supported by the science and academia work group. Women scientists Low‑importance This article is within the scope of WikiProject Women scientists, a collaborative effort to improve the coverage of Women in science on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks. Low This article has been rated as Low-importance on the project's importance scale.

The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view. SiewNg (talk · contribs) This user has contributed to the article. This user has declared a connection.

Talk:Siew C. Ng

Conflict of Interest Disclosure

I am a colleague of Professor Siew C. Ng at The Chinese University of Hong Kong. I have revised this draft with independent sources (e.g., South China Morning Post, Nature Portfolio, BBC Science Focus, HKTDC Research, News-Medical.net, Research Communities by Springer Nature) to address notability and avoid self-promotion. I welcome editorial feedback. SiewNg (talk) 07:18, 26 June 2025 (UTC)[reply]

The user below has a request that an edit be made to Siew C. Ng. That user has an actual or apparent conflict of interest. The requested edits backlog is very high. Please be extremely patient. There are currently 246 requests waiting for review. Please read the instructions for the parameters used by this template for accepting and declining them, and review the request below and make the edit if it is well sourced, neutral, and follows other Wikipedia guidelines and policies.

I am a colleague of at CUHK. I have revised this draft with independent sources to address neutrality, verifiability, and notability, and avoid self-promotion. I welcome editorial feedback.

• Specific change: Please add the following **sourced** updates to the article:

1. In **Ng Siew Chien** section, after "She has led international studies on IBD epidemiology in the Asia-Pacific region":

  → Add: "she has published over 420 peer-reviewed papers in leading journals including Nature, Nature Medicine, The Lancet and Nature Microbiology.[1][2][3][4]

2. **Career** – delete and add to list:

  → Delete: "She has collaborated with over 20 countries and 30 centers in the Asia-Pacific on IBD studies.[5][6]

  → Add: "She is at the forefront of epidemiology, genetics and pathogenesis of IBD and has led over 30 countries and 100 centers in Asia-Pacific to study IBD.[7][8] In 2017, she established Asia’s First Microbiota Transplantation (FMT) Research Center which is now sole provider of FMT service to all Hong Kong public hospitals.[9] [10] She has co-established two biotechnology companies focusing on first-in-class microbial diagnostics and therapeutics.[11]

3. **Awards and recognition section** – add to list:

 → Change: "Ng has been a Highly Cited Researcher by Clarivate since 2020" to "She was named Highly-cited researchers by Clarivate for 5 consecutive years since 2020.[12]

• Reason: These updates enhance the article with a recent introduction, career information, awards, and recognition, supported by independent reporting. These updates are from reliable, independent sources. Thank you.

SiewNg (talk) 09:39, 3 November 2025 (UTC)[reply]

Proposed Revision

To address cleanup and COI concerns, I suggest this revision for improved clarity and neutrality. I am a CUHK colleague of Siew C. Ng and have disclosed COI. Changes include simplified prose, expanded context, and updated citations. I welcome third-party edits.SiewNg (talk)

Comments left by AfC reviewers

• Comment: I did note that she is a named professor, so have left this comment to alert you. I will now resubmit on your behalf and accept. 🇵🇸‍🇺🇦 Fiddle^Timtrent Faddle^Talk to me 🇺🇦‍🇵🇸 07:50, 26 June 2025 (UTC)[reply]

• Comment: You have a referencing issue, but not in the way you might expect.
  It is WP:CITEKILL. Instead we need one excellent reference per fact asserted. If you are sure it is beneficial, two, and at an absolute maximum, three. Three is not a target, it's a limit. Aim for one. A fact you assert, once verified in a reliable source, is verified. More is gilding the lily. Please choose the very best in each case of multiple referencing for a single point and either drop or repurpose the remainder.
  Citekill creates WP:BOMBARD, which gives the impression that you are desperate prove notability. This is not needed. They either pass WP:BIO, or the more targeted WP:NPROF or they do not. 🇵🇸‍🇺🇦 Fiddle^Timtrent Faddle^Talk to me 🇺🇦‍🇵🇸 07:48, 26 June 2025 (UTC)[reply]

Addressing Article Issues

I have added internal links to improve integration and will review talk page comments for cleanup. As a colleague of Siew C. Ng, I’ve disclosed COI and will seek neutral edits. Suggestions welcome! SiewNg (talk) 09:47, 26 June 2025 (UTC)[reply]

Addressing Article Issues

Cleanup Plan

I will review talk page comments and improve the article’s clarity and completeness. Suggestions welcome! I have edited this article and will focus on neutral, verifiable content from independent sources. I welcome third-party edits and feedback. SiewNg (talk) 08:46, 27 June 2025 (UTC)[reply]

Introduction, Career, and Awards and recognition update (2025)

This edit request by an editor with a conflict of interest was declined. Some or all of the changes weren't supported by neutral, independent, reliable sources. Consider re-submitting with content based on media, books and scholarly works.

Please add the following **sourced** updates to the article:

1. In **Ng Siew Chien** section, after "She has led international studies on IBD epidemiology in the Asia-Pacific region":

  → Add: "she has published over 420 peer-reviewed papers in leading journals including Nature, Nature Medicine, The Lancet and Nature Microbiology.[13][14][15][16]

2. **Career** – delete and add to list:

  → Delete: "She has collaborated with over 20 countries and 30 centers in the Asia-Pacific on IBD studies.[17][18]

  → Add: "She is at the forefront of epidemiology, genetics and pathogenesis of IBD and has led over 30 countries and 100 centers in Asia-Pacific to study IBD.[19][20] In 2017, she established Asia’s First Microbiota Transplantation (FMT) Research Center which is now sole provider of FMT service to all Hong Kong public hospitals.[21] [22] She has co-established two biotechnology companies focusing on first-in-class microbial diagnostics and therapeutics.[23]

3. **Awards and recognition section** – add to list:

 → Change: "Ng has been a Highly Cited Researcher by Clarivate since 2020" to "She was named Highly-cited researchers by Clarivate for 5 consecutive years since 2020.[24]

These are from reliable, independent sources. Thank you.

SiewNg (talk) 07:48, 31 October 2025 (UTC)[reply]

References

1. Hracs, L.; Ng, S.C. (2025). "Global evolution of inflammatory bowel disease across epidemiologic stages". Nature. doi:10.1038/s41586-025-08940-0.
2. Zheng, Jiaying; Ng, S.C. (2024). "Noninvasive, microbiome-based diagnosis of inflammatory bowel disease". Nature Medicine. doi:10.1038/s41591-024-03280-4.
3. Ng, S.C. (2017). "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies". The Lancet. doi:10.1016/S0140-6736(17)32448-0.
4. Su, Qi; Ng, S.C. (2024). "Multikingdom and functional gut microbiota markers for autism spectrum disorder". Nature Microbiology. doi:10.1038/s41564-024-01739-1.
5. Mak, JWY; Ng, S.C. (2023). "Development of GIVES-21". BMC Medical Research Methodology. 23 (129): 129. doi:10.1186/s12874-023-01944-2. PMC 10209572. PMID 37231405.
6. Ran, Z.; Ng, S.C. (2021). "Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia". Journal of Gastroenterology and Hepatology. 36 (3): 637–645. doi:10.1111/jgh.15185. PMID 32672839.
7. Mak, JWY; Ng, S.C. (2023). "Development of GIVES-21". BMC Medical Research Methodology. 23 (129): 129. doi:10.1186/s12874-023-01944-2. PMC 10209572. PMID 37231405.
8. Hracs, L.; Ng, S.C. (2025). "Global evolution of inflammatory bowel disease across epidemiologic stages". Nature. doi:10.1038/s41586-025-08940-0.
9. Yau, Yuk Kam; Ng, S.C. (2023). "Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry". Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2023.09.001.
10. Su, Qi; Ng, S.C. (2024). "Multikingdom and functional gut microbiota markers for autism spectrum disorder". Nature Microbiology. doi:10.1038/s41564-024-01739-1.
11. "MicroSigX: The Hong Kong Biotech Transforming Autism Detection Through Gut Science". Forbes Asia Custom. 2025. Retrieved 2025-10-31.
12. "Ng, Siew C". Clarivate. Retrieved 2025-10-31.
13. Hracs, L.; Ng, S.C. (2025). "Global evolution of inflammatory bowel disease across epidemiologic stages". Nature. doi:10.1038/s41586-025-08940-0.
14. Zheng, Jiaying; Ng, S.C. (2024). "Noninvasive, microbiome-based diagnosis of inflammatory bowel disease". Nature Medicine. doi:10.1038/s41591-024-03280-4.
15. Ng, S.C. (2017). "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies". The Lancet. doi:10.1016/S0140-6736(17)32448-0.
16. Su, Qi; Ng, S.C. (2024). "Multikingdom and functional gut microbiota markers for autism spectrum disorder". Nature Microbiology. doi:10.1038/s41564-024-01739-1.
17. Mak, JWY; Ng, S.C. (2023). "Development of GIVES-21". BMC Medical Research Methodology. 23 (129): 129. doi:10.1186/s12874-023-01944-2. PMC 10209572. PMID 37231405.
18. Ran, Z.; Ng, S.C. (2021). "Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia". Journal of Gastroenterology and Hepatology. 36 (3): 637–645. doi:10.1111/jgh.15185. PMID 32672839.
19. Mak, JWY; Ng, S.C. (2023). "Development of GIVES-21". BMC Medical Research Methodology. 23 (129): 129. doi:10.1186/s12874-023-01944-2. PMC 10209572. PMID 37231405.
20. Hracs, L.; Ng, S.C. (2025). "Global evolution of inflammatory bowel disease across epidemiologic stages". Nature. doi:10.1038/s41586-025-08940-0.
21. Yau, Yuk Kam; Ng, S.C. (2023). "Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry". Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2023.09.001.
22. Su, Qi; Ng, S.C. (2024). "Multikingdom and functional gut microbiota markers for autism spectrum disorder". Nature Microbiology. doi:10.1038/s41564-024-01739-1.
23. "MicroSigX: The Hong Kong Biotech Transforming Autism Detection Through Gut Science". Forbes Asia Custom. 2025. Retrieved 2025-10-31.
24. "Ng, Siew C". Clarivate. Retrieved 2025-10-31.

I've updated the edit tag to {{Edit COI}}. meamemg (talk) 14:44, 31 October 2025 (UTC)[reply]

 Not done: The changes are not supported by neutral, independent, reliable sources. Please provide reliable sources that support the change you want to be made. 

The majority of the sources you have provided are authored by the subject of the article. That means they are not independent. For instance, if you want the statement "she has published over 420 peer-reviewed papers" added to the article, then you need to supply a source, not written by the subject, that supports that claim. Could you please try again using sources independent of the subject? DrThneed (talk) 04:42, 10 November 2025 (UTC)[reply]